Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Ensuring Tamper Evidence in Injectable Packaging – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Ensuring Tamper Evidence in Injectable Packaging – V 2.0

Standard Operating Procedure for Ensuring Tamper Evidence in Injectable Packaging


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/097/2025
Supersedes SOP/SIM/097/2022
Page No. Page 1 of 11
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define the procedure for implementing and verifying tamper-evident features in the packaging of sterile injectable products in order to maintain product integrity and meet regulatory requirements.

2. Scope

This SOP applies to all sterile injectable products manufactured and packaged at the facility,

including vials, ampoules, prefilled syringes, and other sterile dosage forms requiring tamper-evident seals or indicators.

3. Responsibilities

  • Packaging Operator: Ensures tamper-evident materials are applied correctly during packaging operations.
  • IPQA Officer: Monitors and verifies the integrity of tamper-evident features on each batch.
  • Quality Control: Inspects random samples for seal integrity and adherence to specifications.
See also  Sterile Injection Manufacturing: SOP for Packaging of Temperature-Sensitive Injectable Products - V 2.0

4. Accountability

The Packaging Manager is accountable for ensuring all injectable products are packed with appropriate tamper-evident mechanisms as per regulatory expectations.

5. Procedure

5.1 Types of Tamper-Evident Features

  1. Use of flip-off seals for vials with distinct color-coding for each product strength.
  2. Aluminum crimping with breakable evidence for ampoules.
  3. Pre-attached plastic break-away caps for prefilled syringes.
  4. Security holograms or tamper-indicating stickers on secondary cartons.

5.2 Material Inspection

  1. Inspect tamper-evident components upon receipt for visual defects, labeling accuracy, and quantity.
  2. Ensure all incoming packaging components bear batch numbers and are stored separately as per SOP/SIM/096/2025.

5.3 Application in Primary Packaging

  1. During the filling and sealing process, ensure that:
    • Flip-off seals are applied uniformly and pressed firmly.
    • Breakable ampoule necks are flame-sealed accurately.
    • Syringes are capped with pre-tensioned tamper-proof caps.
  2. Packaging line in-process checks must verify 100% application of seals and alignment.
See also  Sterile Injectable Manufacturing: SOP for Sanitization of Portable Water Systems - V 2.0

5.4 Secondary Packaging Verification

  1. Verify holograms or stickers are positioned as per packaging artwork on each carton.
  2. IPQA must inspect random samples from every batch to confirm seal integrity and tamper-evidence visibility.

5.5 Defect Management

  1. Any product with misaligned, damaged, or missing tamper seals shall be rejected and recorded in the deviation log (Annexure-2).
  2. Defective materials shall be stored in a designated area and disposed of as per SOP/QC/REJ/011.

5.6 Training and Awareness

  1. All personnel involved in packaging shall be trained annually on tamper-evident features and visual inspection techniques.
  2. Training records to be maintained (Annexure-3).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • IPQA: In-Process Quality Assurance
  • QC: Quality Control

7. Documents

  1. Tamper-Evident Component Receipt Log – Annexure-1
  2. Deviation Log – Annexure-2
  3. Training Record – Annexure-3

8. References

  • 21 CFR Part 211.132 – Tamper-evident packaging requirements for over-the-counter (OTC) human drug products
  • EU GMP Guidelines – Annex 16: Certification by a Qualified Person
  • WHO TRS 986 Annex 2 – GMP Guidelines for Pharmaceutical Products
See also  Sterile Injectable Manufacturing: SOP for Training Personnel in Aseptic Manufacturing - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Tamper-Evident Component Receipt Log

Date Material Batch No. Qty Received By
15/06/2025 Flip-off seals (Red) FOS-1023 20,000 Rajesh Kumar

Annexure-2: Deviation Log

Date Batch No. Description of Deviation Corrective Action Approved By
16/06/2025 INJ-097 10 cartons missing hologram Line rechecked and replaced Sunita Reddy

Annexure-3: Training Record

Employee Name Department Training Date Trainer Status
Ajay Verma Packaging 10/06/2025 QA Officer Completed

Revision History

Revision Date Revision No. Details Reason Approved By
01/04/2022 1.0 Initial version New SOP Head QA
18/06/2025 2.0 Included secondary packaging hologram inspection Periodic review Head QA
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Aerosol: SOP for Conducting Assay Testing of Active Ingredients in Aerosols – V 2.0
Next Post: Elixir Department: SOP for Operation of Flow Meter for Liquid Transfer – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version